Literature DB >> 20302520

Chaperone-assisted degradation: multiple paths to destruction.

Nadja Kettern1, Michael Dreiseidler, Riga Tawo, Jörg Höhfeld.   

Abstract

Molecular chaperones are well known as facilitators of protein folding and assembly. However, in recent years multiple chaperone-assisted degradation pathways have also emerged, including CAP (chaperone-assisted proteasomal degradation), CASA (chaperone-assisted selective autophagy), and CMA (chaperone-mediated autophagy). Within these pathways chaperones facilitate the sorting of non-native proteins to the proteasome and the lysosomal compartment for disposal. Impairment of these pathways contributes to the development of cancer, myopathies, and neurodegenerative diseases. Chaperone-assisted degradation thus represents an essential aspect of cellular proteostasis, and its pharmacological modulation holds the promise to ameliorate some of the most devastating diseases of our time. Here, we discuss recent insights into molecular mechanisms underlying chaperone-assisted degradation in mammalian cells and highlight its biomedical relevance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20302520     DOI: 10.1515/BC.2010.058

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  77 in total

Review 1.  Ubiquitination and selective autophagy.

Authors:  S Shaid; C H Brandts; H Serve; I Dikic
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

Review 2.  Chaperone-mediated autophagy: machinery, regulation and biological consequences.

Authors:  Wenming Li; Qian Yang; Zixu Mao
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

3.  Aptamer-Enabled Manipulation of the Hsp70 Chaperone System Suggests a Novel Strategy for Targeted Ubiquitination.

Authors:  Deepak Thirunavukarasu; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2015-12-07       Impact factor: 5.486

Review 4.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

Review 5.  Context-dependent resistance to proteolysis of intrinsically disordered proteins.

Authors:  Marcin J Suskiewicz; Joel L Sussman; Israel Silman; Yosef Shaul
Journal:  Protein Sci       Date:  2011-06-08       Impact factor: 6.725

Review 6.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

7.  SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases.

Authors:  Mathew B Wong; Jacob Goodwin; Anwar Norazit; Adrian C B Meedeniya; Christiane Richter-Landsberg; Wei Ping Gai; Dean L Pountney
Journal:  Neurotox Res       Date:  2012-11-15       Impact factor: 3.911

8.  UBL/BAG-domain co-chaperones cause cellular stress upon overexpression through constitutive activation of Hsf1.

Authors:  Esben G Poulsen; Caroline Kampmeyer; Franziska Kriegenburg; Jens V Johansen; Kay Hofmann; Christian Holmberg; Rasmus Hartmann-Petersen
Journal:  Cell Stress Chaperones       Date:  2016-12-14       Impact factor: 3.667

9.  Hsp90 Maintains Proteostasis of the Galactose Utilization Pathway To Prevent Cell Lethality.

Authors:  Rajaneesh Karimpurath Gopinath; Jun-Yi Leu
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

10.  A Two-step Protein Quality Control Pathway for a Misfolded DJ-1 Variant in Fission Yeast.

Authors:  Søs G Mathiassen; Ida B Larsen; Esben G Poulsen; Christian T Madsen; Elena Papaleo; Kresten Lindorff-Larsen; Birthe B Kragelund; Michael L Nielsen; Franziska Kriegenburg; Rasmus Hartmann-Petersen
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.